1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Poland Pharmaceuticals and Healthcare Report Q2 2016

Poland Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 85 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: PLN33.39bn (USD8.86bn) in 2015 to PLN34.76bn (USD8.61bn) in 2016; +4.1% inlocal currency terms and -2.8% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: PLN115.74bn (USD30.70bn) in 2015 to PLN121.83bn (USD30.18bn) in 2016; +5.3% inlocal currency terms and -1.7% in US dollar terms. Forecast revised downwards from last quarter.

Table Of Contents

Poland Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Poland 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Poland 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Poland 2012-2020) 17
Prescription Drug Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 22
Generic Drug Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Poland 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Poland 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Poland 2014-2020) 29
Industry Risk Reward Index 30
Central And Eastern Europe Risk/Reward Index 30
Poland Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Advertising Regulations 39
Other Regulatory Developments 40
Intellectual Property Regime 41
Pricing And Reimbursement 43
Pricing Regime 44
Reimbursement Regime 46
Market Overview 52
Healthcare Sector 53
Table: Civilian Outpatient Facilities, 2002-2009 55
Table: Healthcare Resources (Poland 2010-2015) 56
Table: Healthcare Personnel (Poland 2010-2015) 57
Table: Healthcare Activity (Poland 2010-2015) 57
Research and Development 60
Clinical Trials 60
Epidemiology 62
Competitive Landscape 64
Research-Based Industry 64
Table: Multinational Market Activity 65
Pharmaceutical Distribution 66
Pharmaceutical Retail Sector 67
Table: Number Of Pharmacies In Poland, 2004-2009 68
Company Profile 69
Bioton 69
Polpharma 72
Demographic Forecast 74
Demographic Outlook 74
Table: Population Headline Indicators (Poland 1990-2025) 75
Table: Key Population Ratios (Poland 1990-2025) 75
Table: Urban/Rural Population and Life Expectancy (Poland 1990-2025) 76
Table: Population By Age Group (Poland 1990-2025) 76
Table: Population By Age Group % (Poland 1990-2025) 77
Glossary 79
Methodology 81
Pharmaceutical Expenditure Forecast Model 81
Healthcare Expenditure Forecast Model 81
Notes On Methodology 82
Risk/Reward Index Methodology 83
Index Overview 84
Table: Pharmaceutical Risk/Reward Index Indicators 84
Indicator Weightings 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.